Health Care
Commentary
Unaffordable Medicaid Means We Should Forget It
U.S. House Republicans recently released a list of proposals for slashing federal spending by as much as $5.7 trillion. A significant portion of the proposed savings — a whopping $2.3 trillion — would come from Medicaid. Progressives are decrying the GOP document as a heartless assault on an essential safety-net ...
Sally C. Pipes
February 5, 2025
Book
Read the new book from Sally Pipes “The World’s Medicine Chest”
Just released from PRI – read The World’s Medicine Chest, the latest book from PRI President, CEO and Thomas W. Smith Fellow in Health Care Policy. <The World’s Medicine Chest explores how America became the world’s leader in biopharmaceutical innovation through market capitalism. Click here to register to watch a special ...
Sally C. Pipes
February 4, 2025
Commentary
Insulin prices are falling due to market forces — no price caps required
California State Sen. Scott Wiener, D-San Francisco, recently introduced legislation that would cap cost-sharing for insulin at $35 a month, regardless of whether a patient has public or private insurance. It’s a popular idea. But it may not be necessary. The cost of insulin has been falling due to market ...
Sally C. Pipes
February 4, 2025
Commentary
The CFPB’s New Medical Debt Rule Will Do More Harm Than Good
The Biden administration issued a flurry of directives in its final days. One move in particular warrants closer inspection. On January 7, the Consumer Financial Protection Bureau finalized a rule barring medical debt from appearing on credit reports. According to the agency, the rule will wipe $49 billion in medical ...
Sally C. Pipes
February 3, 2025
Commentary
Patients Pay Dearly for Biden’s Pricing Mess
On Jan. 17, just days before leaving office, the Biden administration announced the next 15 prescription drugs dispensed through Medicare Part D that will be subject to price controls on Jan. 1, 2027, under the terms of the Inflation Reduction Act. Among them is the blockbuster semaglutide, a prescription medication ...
Sally C. Pipes
January 29, 2025
Commentary
RFK Jr.’s Confirmation Hearings Can’t Leave This Question Unanswered
On this Wednesday and Thursday, two powerful Senate committees will hold confirmation hearings for Robert F. Kennedy Jr., President Trump’s nominee to lead the Department of Health and Human Services. RFK Jr. is no stranger to controversy. But his most radical policy position may be one that relatively few people ...
Sally C. Pipes
January 29, 2025
Commentary
Republicans, don’t give up on healthcare reform
In his first week back in the White House, President Donald Trump issued several executive orders related to health policy. But lasting action on healthcare reform, from reining in wasteful or fraudulent Medicaid spending to rolling back billions in premium subsidies, can only come from Congress, which holds the power ...
Sally C. Pipes
January 27, 2025
Commentary
Creative Counting Can’t Fix The Inflation Reduction Act’s Flaws
Just three days before President Biden left office, his appointees tried to tie incoming Trump staffers’ hands on a health policy decision that affects millions of Americans and tens of billions in federal spending. On January 17, the Centers for Medicare & Medicaid Services announced a new list of 15 ...
Sally C. Pipes
January 27, 2025
Commentary
California could lead the way on bipartisan prescription drug reform
California State Senator Scott Wiener, D-San Francisco, recently introduced a bill aimed at reining in pharmacy benefit managers (PBMs), the middlemen largely responsible for the dysfunction plaguing our nation’s prescription drug market. Wiener’s effort should attract the support of lawmakers on both the left and right. By cracking down on ...
Sally C. Pipes
January 24, 2025
Commentary
Record Obamacare Enrollment Embarrassment Masquerades as Victory
Just under 24 million Americans have purchased health coverage through the Affordable Care Act’s exchanges for 2025, marking yet another year of record-high enrollment. As in previous years, the Biden administration was quick to declare this surge in sign-ups a victory for patients. “Every American should have access to quality, ...
Sally C. Pipes
January 22, 2025
Unaffordable Medicaid Means We Should Forget It
U.S. House Republicans recently released a list of proposals for slashing federal spending by as much as $5.7 trillion. A significant portion of the proposed savings — a whopping $2.3 trillion — would come from Medicaid. Progressives are decrying the GOP document as a heartless assault on an essential safety-net ...
Read the new book from Sally Pipes “The World’s Medicine Chest”
Just released from PRI – read The World’s Medicine Chest, the latest book from PRI President, CEO and Thomas W. Smith Fellow in Health Care Policy. <The World’s Medicine Chest explores how America became the world’s leader in biopharmaceutical innovation through market capitalism. Click here to register to watch a special ...
Insulin prices are falling due to market forces — no price caps required
California State Sen. Scott Wiener, D-San Francisco, recently introduced legislation that would cap cost-sharing for insulin at $35 a month, regardless of whether a patient has public or private insurance. It’s a popular idea. But it may not be necessary. The cost of insulin has been falling due to market ...
The CFPB’s New Medical Debt Rule Will Do More Harm Than Good
The Biden administration issued a flurry of directives in its final days. One move in particular warrants closer inspection. On January 7, the Consumer Financial Protection Bureau finalized a rule barring medical debt from appearing on credit reports. According to the agency, the rule will wipe $49 billion in medical ...
Patients Pay Dearly for Biden’s Pricing Mess
On Jan. 17, just days before leaving office, the Biden administration announced the next 15 prescription drugs dispensed through Medicare Part D that will be subject to price controls on Jan. 1, 2027, under the terms of the Inflation Reduction Act. Among them is the blockbuster semaglutide, a prescription medication ...
RFK Jr.’s Confirmation Hearings Can’t Leave This Question Unanswered
On this Wednesday and Thursday, two powerful Senate committees will hold confirmation hearings for Robert F. Kennedy Jr., President Trump’s nominee to lead the Department of Health and Human Services. RFK Jr. is no stranger to controversy. But his most radical policy position may be one that relatively few people ...
Republicans, don’t give up on healthcare reform
In his first week back in the White House, President Donald Trump issued several executive orders related to health policy. But lasting action on healthcare reform, from reining in wasteful or fraudulent Medicaid spending to rolling back billions in premium subsidies, can only come from Congress, which holds the power ...
Creative Counting Can’t Fix The Inflation Reduction Act’s Flaws
Just three days before President Biden left office, his appointees tried to tie incoming Trump staffers’ hands on a health policy decision that affects millions of Americans and tens of billions in federal spending. On January 17, the Centers for Medicare & Medicaid Services announced a new list of 15 ...
California could lead the way on bipartisan prescription drug reform
California State Senator Scott Wiener, D-San Francisco, recently introduced a bill aimed at reining in pharmacy benefit managers (PBMs), the middlemen largely responsible for the dysfunction plaguing our nation’s prescription drug market. Wiener’s effort should attract the support of lawmakers on both the left and right. By cracking down on ...
Record Obamacare Enrollment Embarrassment Masquerades as Victory
Just under 24 million Americans have purchased health coverage through the Affordable Care Act’s exchanges for 2025, marking yet another year of record-high enrollment. As in previous years, the Biden administration was quick to declare this surge in sign-ups a victory for patients. “Every American should have access to quality, ...